These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4040433)

  • 1. [Problems with the Czechoslovak cytostatic agent Benin Spofa].
    Grafnetterová J; König J; Krepelka J; Cerný A; Klíma J; Krebs V; Charvát J
    Cas Lek Cesk; 1985 Jun; 124(26):820-3. PubMed ID: 4040433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances of research on the action of purinergic drugs and hereditary polymorphism of thiopurine methyltransferase].
    Liang A; Guo L
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):110-2. PubMed ID: 10921112
    [No Abstract]   [Full Text] [Related]  

  • 3. [Individual monitoring of thiopurine and methotrexate treatment].
    Baslund B; Dalhoff KP; Schmiegelow K
    Ugeskr Laeger; 2005 May; 167(20):2177-9. PubMed ID: 15987078
    [No Abstract]   [Full Text] [Related]  

  • 4. The binding of the sulfur and oxygen purine derivatives with bovine serum albumin.
    Sochacka J; Sułkowska A; Kowalska A
    Acta Pol Pharm; 2008; 65(1):169-71. PubMed ID: 18536193
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment.
    van Asseldonk DP; Seinen ML; de Boer NK; van Bodegraven AA; Mulder CJ
    J Crohns Colitis; 2012 Feb; 6(1):95-101. PubMed ID: 22261533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the tolerance and pharmacokinetics of butocin in persons with progressive polyarthritis].
    Buchar E; Perlík F; Novotná P; Janků I
    Cesk Farm; 1985 Jul; 34(6):228-31. PubMed ID: 3896530
    [No Abstract]   [Full Text] [Related]  

  • 7. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
    Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogen update: azathioprine and 6-mercaptopurine.
    Polifka JE; Friedman JM
    Teratology; 2002 May; 65(5):240-61. PubMed ID: 11967923
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bone marrow depression after azathioprine. New discoveries on an old drug].
    Löwhagen GB; Lindstedt G
    Lakartidningen; 2000 Feb; 97(5):458-62. PubMed ID: 10707497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
    Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
    Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2.
    Nagai K; Nagasawa K; Kihara Y; Okuda H; Fujimoto S
    Int J Pharm; 2007 Mar; 333(1-2):56-61. PubMed ID: 17088032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of azathioprine and 6-mercaptopurine: methodological aspects and preliminary results in uremic patients.
    Odlind B; Grefberg N; Hartvig P; Lindström B; Lönnerholm G
    Scand J Urol Nephrol Suppl; 1981; 64():213-9. PubMed ID: 6815791
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved pharmacokinetics of mercaptopurine afforded by a thermally robust hemihydrate.
    Kersten KM; Matzger AJ
    Chem Commun (Camb); 2016 Apr; 52(30):5281-4. PubMed ID: 27002860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione-dependent metabolism of cis-3-(9H-purin-6-ylthio)acrylic acid to yield the chemotherapeutic drug 6-mercaptopurine: evidence for two distinct mechanisms in rats.
    Gunnarsdottir S; Elfarra AA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):950-7. PubMed ID: 10454464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an HPLC method for the rapid and simultaneous determination of 6-mercaptopurine and four of its metabolites in plasma and red blood cells.
    Hawwa AF; Millership JS; Collier PS; McElnay JC
    J Pharm Biomed Anal; 2009 Feb; 49(2):401-9. PubMed ID: 19095392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Better therapeutic potential for azathioprine and mercaptopurine].
    Bergan S; Norge O
    Lakartidningen; 2000 Apr; 97(16):1999-2000. PubMed ID: 10826362
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposphere based lipoprotein-mimetic delivery system for 6-mercaptopurine.
    Khopade AJ; Shelly C; Pandit NK; Banakar UV
    J Biomater Appl; 2000 Apr; 14(4):389-98. PubMed ID: 10794509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SERS protocol as a potential tool to access 6-mercaptopurine release accelerated by glutathione-S-transferase.
    Wang Y; Sun J; Yang Q; Lu W; Li Y; Dong J; Qian W
    Analyst; 2015 Nov; 140(22):7578-85. PubMed ID: 26455313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of butocine.
    Grafnetterová J; Smahel O; König J; Matl I
    Neoplasma; 1978; 25(2):203-9. PubMed ID: 643124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].
    Cha JM; Kim HJ
    Korean J Gastroenterol; 2008 May; 51(5):319-22. PubMed ID: 18516018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.